Oxygesic Dispersa (Oxycodone Hydrochloride)

Oxygesic Dispersa is an opioid analgesic that acts on the central nervous system to relieve pain.

• Acute postoperative pain: provides effective relief following surgical procedures.
• Cancer‑related pain: helps control persistent pain associated with malignant disease.
• Severe chronic non‑cancer pain: reduces intensity of long‑standing pain unresponsive to non‑opioid therapies.
• Traumatic injury pain: alleviates pain from major injuries such as fractures or burns.
• Palliative care pain: improves comfort in end‑of‑life care settings.

• Oxycodone binds primarily to µ‑opioid receptors in the brain and spinal cord, activating inhibitory G‑protein pathways that reduce neuronal excitability and diminish the transmission of nociceptive signals. This receptor activation also modulates descending pain pathways, producing analgesia throughout the central nervous system.

Adverse reactions may vary in frequency and severity.

Common Side Effects

• Nausea: mild to moderate upset stomach.
• Constipation: reduced bowel movements.
• Drowsiness: increased sleepiness or fatigue.
• Dizziness: sensation of light‑headedness.
• Dry mouth: reduced salivation.
• Pruritus: mild itching.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing.
• Severe hypotension: marked drop in blood pressure.
• Opioid dependence or addiction: potential for misuse.
• Seizures: rare convulsive episodes.
• Anaphylaxis: acute allergic reaction with hives or swelling.
• adrenal insufficiency: rare hormonal imbalance affecting stress response.

When prescribing Oxygesic Dispersa, clinicians should consider several safety measures.

• Assess pain severity: confirm that opioid therapy is appropriate.
• Evaluate respiratory function: monitor for signs of depression.
• Review patient history: check for substance use disorder risk.
• Adjust for renal/hepatic impairment: dose may need modification.
• Avoid concurrent CNS depressants: limit additive sedation.
• Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Oxygesic Dispersa can interact with other medications, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Benzodiazepines: combined use can cause profound respiratory depression.
• Central nervous system depressants: may intensify sedation and respiratory effects.
• MAO‑inhibitors: can precipitate severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely)

• Anticholinergic agents: may worsen constipation.
• CYP3A4 inhibitors (e.g., ketoconazole): increase oxycodat e levels.
• CYP3A4 inducers (e.g., rifampicin): reduce oxycodone concentrations.
• Diuretics: may enhance hypotensive effects.
• Antidepressants (SSRIs): potential for serotonin syndrome in rare cases.